1. Home
  2. IPSC vs SOPH Comparison

IPSC vs SOPH Comparison

Compare IPSC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.22

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.46

Market Cap

374.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
SOPH
Founded
2019
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
441.9M
374.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IPSC
SOPH
Price
$2.22
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.25
$7.50
AVG Volume (30 Days)
902.3K
105.6K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
91.30
N/A
EPS
N/A
N/A
Revenue
$109,164,000.00
N/A
Revenue This Year
N/A
$23.09
Revenue Next Year
N/A
$19.57
P/E Ratio
N/A
N/A
Revenue Growth
1556.76
N/A
52 Week Low
$0.44
$2.59
52 Week High
$2.97
$5.70

Technical Indicators

Market Signals
Indicator
IPSC
SOPH
Relative Strength Index (RSI) 48.41 63.36
Support Level $2.13 $4.54
Resistance Level $2.45 $5.65
Average True Range (ATR) 0.16 0.30
MACD -0.01 0.05
Stochastic Oscillator 43.12 93.19

Price Performance

Historical Comparison
IPSC
SOPH

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: